SISTEMA CARDIOVASCULAR (Spanish Edition)
Emphasis is needed on quality of care to reduce barriers related to social, economic, and cultural factors and to improve social protection for health, particularly among vulnerable populations. In order to face these challenges, PAHO's action plan considers that prevention and management of chronic diseases requires integration through strengthened referrals and relationships among primary, secondary, and tertiary levels of care. The entire spectrum of disease management from prevention to screening and early detection, diagnosis, treatment, self-care, rehabilitation, and palliative care is necessary.
The constructs of the Chronic Care Model 1 shown above are incorporated into the objective for the management of chronic diseases and risk factors, and are aimed at improving outcomes in five main areas :. This plan also considers technical assistance for chronic disease programs, the reorientation of health services towards chronic diseases, and improved access to essential medicines and technologies.
PAHO's strategy recognizes the call for a renewed approach to primary health care and the highest attainable level of health for everyone as emphasized in the Regional Declaration on the New Orientations for Primary Health Care promulgated at the 46 th Directing Council. Also reflected in this plan is Resolution CD R7: Access to Medicines , which prioritizes access to medicine and other health supplies. Health Technology Manual. A method of predicting arrhythmogenic potential of antihistamines in humans. Drug Safety.
QT Prodact: a multi-site study of in vitro action potential assays on 21 compounds in isolated guinea-pig papillary muscles.. J Pharmacol Sci, 99 , pp. Comparison of cardiovascular effects of a novel class IC atiarrhythmic agent, NIK, with those of flecainide in isolated canine heart preparations cross-circulated with a donor dog.. Jpn J Pharmaco, 56 , pp. Assessment of ischemic injury and protective interventions: the Langendorff versus the working rat heart preparation.. Can J Cardiol, 6 , pp. Echo-wave termination of ventricular tachycardia. A common mechanism of termination of reentrant arrhythmias by various pharmacological interventions..
Circulation, 85 , pp.
Polymorphic reentrant ventricular tachycardia in the isolated rabbit heart studied by high-density mapping.. Alteration of ventricular fibrillation by flecainide, verapamil, and sotalol: an experimental study.. Modification of ventricular fibrillation activation patterns induced by local stretching.. J Cardiovasc Electrophysiol, 16 , pp. Rev Esp Cardiol, 61 , pp. Current status of monophasic action potential recording: theories, measurements and interpretations.. Cardiovasc Res, 41 , pp. Spatial and temporal organization during cardiac fibrillation..
Nature, , pp. Effect of remodelling, stretch and ischemia on ventricular fibrillation frequency and dynamics in a heart failure model.. Cardiovasc Res, 65 , pp. Frequency analysis of ventricular fibrillation in swine ventricles.. Circ Res, 90 , pp. Knockin animal models of inherited arrhythmogenic diseases: what have we learned from them..
J Cardiovasc Electrophysiol, 18 , pp. Rapid regression of atherosclerosis: insights from the clinical and experimental literature.. Nat Clin Pract Cardiovasc Med, 5 , pp. Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoE and LDLr mice.. Clin Chem Lab Med, 43 , pp. Transgenic models of heart failure: Elucidation of the molecular mechanisms of heart disease.. Heart Fail Clin, 1 , pp. Calcium regulatory proteins and their alteration by transgenic approaches.. Am J Cardiol, 83 , pp. Transgenic mouse models for cardiac dysfunction by a specific gene manipulation..akanreftiadlin.ga/map21.php
Doppelherz health products - the product range
Connexin 43 and ischemic preconditioning.. Cardiovasc Res, 62 , pp. Pharmacol Rev, 59 , pp. Proc Soc Exp Biol Med. Studies of regression of advanced atherosclerosis in experimental animals and man.. Ann N Y Acad Sci, , pp. Intravenous injection of rabbit apolipoprotein A-I inhibits the progression of atherosclerosis in cholesterolfed rabbits..
Arterioscler Thromb Vasc Biol, 15 , pp. Lipid lowering reduces proteolytic and prothrombotic potential in rabbit atheroma.. Intravenously administered lecithin liposomes: a synthetic antiatherogenic lipid particle.. Perspect Biol Med, 27 , pp. Nutritional control of coronary artery atherosclerosis in the squirrel monkey.. J Atheroscler Res, 8 , pp. Evidence of regression of atherosclerosis in primates and man.. Postgrad Med J, 52 , pp. Regression of coronary atheromatosis in rhesus monkeys.. Circ Res, 27 , pp. Sequential morphologic studies of regression of advanced atherosclerosis..
Arch Pathol Lab Med, , pp. High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein HDL particles comparable to human HDL J Biol Chem, , pp. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells..
PAHO/WHO | Integrated Disease Management
Cell, 71 , pp. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice.. Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice.. J Clin Invest, , pp. Acute regression of advanced and retardation of early aortic atheroma in immunocompetent apolipoprotein-E apoE decidient mice by administration of a second generation [E1 - , E3 - , polymerase - adenovirus vector expressing human apoE..
¿Qué es la enfermedad cardiovascular?
Hum Mol Genet, 11 , pp. Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice.. Serial studies of mouse atherosclerosis by in vivo magnetic resonance imaging detect lesion regression after correction of dyslipidemia.. Arterioscler Thromb Vasc Biol, 24 , pp. Moderate daily intake of red wine inhibits mural thrombosis and monocyte tissue factor expression in an experimental porcine model.. Characterization of a tubular flow chamber for studying platelet interaction with biologic and prosthetics materials: deposition of indium labeled platelets on collagen, subendothelium and expanded polytetrafluorethylene..
J Lab Clin Med, , pp. Cardiovasc Dis, 2 , pp. Factors influencing infarct size following experimental coronary artery occlusion.. Circulation, 43 , pp. En: The pathophysiology of myocardial perfusion. Schaper W, editor. Amsterdam: Elsevier; Eur Heart J. Cardiovasc Drugs Ther, 2 , pp. Fine structural changes in myocardial ischemic injury..
Arch Pathol, 79 , pp. Circ Res. Total ischemia in dog hearts, in vitro. Comparison of high energy phosphate production, utilization, and depletion, and of adenine nucleotide catabolism in total ischemia in vitro vs severe ischemia in vivo.. Circ Res, 49 , pp. Ischemia-reperfusion and immediate T cell responses.. Cell Immunol, , pp. Mitochondrial membrane permeabilization in cell death.. Physiol Rev, 87 , pp.
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.. Circulation, 74 , pp. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning.. Am J Physiol, , pp. Preconditioning the myocardium: from cellular physiology to clinical cardiology.. Physiol Rev, 83 , pp. Survival kinases in ischemic preconditioning and postconditioning.. Cardiovasc Res, 70 , pp. The ubiquitous role of nitric oxide in cardioprotection.. J Mol Cell Cardiol, 40 , pp. Reactive oxygen species as mediators of signal transduction in ischemic preconditioning..
Antioxid Redox Signal, 6 , pp. Translocation of connexin 43 in the inner mithocondrial membrane of cardiomyocytes through the heat shock protein dependent TOM pathway and its importance in cardioprotection.. Circ Res, 99 , pp. Bringing preconditioning and postconditioning into focus.. Vet Res Commun. Physiological assessment of complex cardiac phenotypes in genetically engineered mice..
H Medline. Reversible congestive heart failure due to chronic rapid stimulation of the normal heart.. Proc N Engl Cardiovasc Soc, 20 , pp. Cardiac ionic currents and acute ischemia: from channels to arrhythmias.. Physiol Rev, 79 , pp. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction.. Physiol Rev, 69 , pp. The initiation of ventricular fibrillation due to coronary occlusion.. Exp Med Surg, 1 , pp. Delayed development of ventricular ectopic rhythms following experimental coronary occlusion..
Circulation, 1 , pp. Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction: an experimental preparation for sudden cardiac death.. Circulation, 69 , pp. Experimental basis and clinical observations for post-myocardial infarction risk stratification. The heart and cardiovascular system. New York: Raven Press; Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.. Circulation, 92 , pp. Electrical remodelling due to atrial fibrillation in chronically instrumented conscious goats: Roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation..
Circulation, 96 , pp. Chronic rapid atrial pacing.
- Subscribe to our newsletter.
- Famous & Fun Duets, Book 1: 7 Duets for One Piano, Four Hands.
- No customer reviews.
- Winston Dressler?
- ¿Qué son los ácidos grasos omega-3?.
- Anatomy of the Heart and Cardiovascular System | Texas Heart Institute;
- Loves Ripening: Rumi on the Hearts Journey;
Structural, functional and electrophysiological characteristics of a new model of sustained atrial fibrillation.. Circulation, 91 , pp.
Pathophysiology and prevention of atrial fibrillation.. Right atrial isolation: a new surgical treatment for supraventricular tachycardia. Surgical technique and electrophysiologic effects.. J Thorac Cardiovasc Surg, 95 , pp. En: Armstrong D. Free Radicals in Diagnostic Medicine. Plenum Press. Kandaswami C, Middleton E: Flavonoids as antioxidants. En: Shahidi F. Champaign, IL. AOCS Press. Lancet ; Hertog MGL: Epidemiological evidence on potential health properties of flavonoids.
Studies in Natural Products Chemistry. Vol 25, part F. Hellner W, Forkmann G: Biosynthesis. En: Harborne JB. The Flavonoids. Advances in Research since Chapman and Hall. Wagner H, Farkas L: Synthesis of flavonoids. Part I. Academic Press. Nishizuka Y: Studies and perspective of protein kinase C.